MAM Easy Active Baby Bottles 11oz, Fast Flow Skinsoft Silicone Nipple with Wide Neck Ergonomic Design, Easy to Hold, BPA-Free, Bottles with Leak-Proof Caps for 4+ Months Baby

At MAM, we partner with medical experts to understand and meet your newborn's needs. The MAM Easy Active 11-ounce Baby Bottle is the epitome of baby feeding solutions, offering a fast-flow, breastfeeding-like silicone nipple that emulates the natural breastfeeding experience to support seamless transitions between breastfeeding and bottle feeding. Whether you're nourishing your little one with baby formula or expressed breast milk, our bottles are crafted to support you every step of the way. MAM Easy Active 11 oz / 325ml Bottle boast a SkinSoft textured nipple, mimicking the feel of breastfeeding to be readily accepted by infants. The flat-shaped nipple is designed to fit snugly in your baby's mouth, simplifying the transition between breast and bottle. These bottles are ergonomically designed for comfort and ease of use by parents and babies, with a wide neck for easy filling and cleaning. They are compatible with nipples for all development stages: Slow Flow (0+ months), Medium Flow (2+ months), Fast Flow (4+ months) & Extra Fast Flow (6+ months), adapting as your baby grows. With a 94% acceptance rate among babies*. These wide-neck baby bottles are made from BPS and BPA-free materials and prioritize your baby's safety and health. MAM is dedicated to sustainability, with bio-circular materials & initiatives to lessen environmental impact. The SkinSoft silicone nipples offer a breastfeeding-like sensation, ensuring maximum comfort during bottle feeding. A leak-proof cap reduces cleanup, and the bottle's ergonomic design facilitates a comfortable feeding experience for both mother and child. The wide neck simplifies filling and cleaning, making MAM's Easy Active Bottles a top choice for ease, comfort, and safety, all underpinned by extensive research**. *Market research, USA 2010, tested with 35 mothers of colicky babies. **Market research 2009-2022, tested with 1,643 babies.